Algorithms for bone mineral density (BMD) management in HIV-infected patients are lacking. Our objective was to assess how often a dual-energy x-ray absorptiometry (DXA) scan should be performed by assessing time of progression to osteopenia/osteoporosis. Methods: All DXA scans performed between 2000 and 2009 from HIV-infected patients with at least two DXA were included. Time to an event (osteopenia and osteoporosis) was assessed using the Kaplan–Meier method. Strata (tertiles) were defined using baseline minimum T scores. Differences between strata in time to an event were compared with the log-rank test. Results: Of 391 patients (1,639 DXAs), 49.6% had osteopenia and 21.7% osteoporosis at their first DXA scan. Of the 112 (28.6%) with n...
Objective: As HIV-infected individuals continue to live longer with antiretroviral therapy (ART), sy...
Objective: Human immunodeficiency virus (HIV) infection and antiretroviral therapy (ART) have been a...
Summary: A meta-analysis was conducted to evaluate the prevalence of osteopenia/osteoporosis in huma...
Algorithms for bone mineral density (BMD) management in HIV-infected patients are lacking. Our objec...
Background: Algorithms for bone mineral density (BMD) management in HIV-infected patients are lackin...
Algorithms for bone mineral density (BMD) management in HIV-infected patients are lacking. Our objec...
none15noLow bone mineral density (BMD) is frequent in HIV infection regardless of the use of antiret...
Background Among HIV-infected individuals, screening for bone disease is encouraged to assess revers...
OBJECTIVES: The burden of reduced bone mineral density (BMD) is high among HIV-infected patients. As...
Introduction: Osteoporosis represents one of the most frequent comorbidity among HIV patients. The c...
Introduction: Reduced bone mass density (BMD) is a frequent observation in HIV-infected persons. Rel...
Introduction: Bone mineral density (BMD) assessment in HIV patients is sparsely done in resource lim...
International audienceBACKGROUND: There is a high prevalence of bone demineralization among HIV-infe...
Purpose: Bone turnover markers (BTM) - aminoterminal propeptide of type 1 collagen (P1NP) and C-term...
HIV is a life-threatening disease that affects millions of people worldwide. Adv...
Objective: As HIV-infected individuals continue to live longer with antiretroviral therapy (ART), sy...
Objective: Human immunodeficiency virus (HIV) infection and antiretroviral therapy (ART) have been a...
Summary: A meta-analysis was conducted to evaluate the prevalence of osteopenia/osteoporosis in huma...
Algorithms for bone mineral density (BMD) management in HIV-infected patients are lacking. Our objec...
Background: Algorithms for bone mineral density (BMD) management in HIV-infected patients are lackin...
Algorithms for bone mineral density (BMD) management in HIV-infected patients are lacking. Our objec...
none15noLow bone mineral density (BMD) is frequent in HIV infection regardless of the use of antiret...
Background Among HIV-infected individuals, screening for bone disease is encouraged to assess revers...
OBJECTIVES: The burden of reduced bone mineral density (BMD) is high among HIV-infected patients. As...
Introduction: Osteoporosis represents one of the most frequent comorbidity among HIV patients. The c...
Introduction: Reduced bone mass density (BMD) is a frequent observation in HIV-infected persons. Rel...
Introduction: Bone mineral density (BMD) assessment in HIV patients is sparsely done in resource lim...
International audienceBACKGROUND: There is a high prevalence of bone demineralization among HIV-infe...
Purpose: Bone turnover markers (BTM) - aminoterminal propeptide of type 1 collagen (P1NP) and C-term...
HIV is a life-threatening disease that affects millions of people worldwide. Adv...
Objective: As HIV-infected individuals continue to live longer with antiretroviral therapy (ART), sy...
Objective: Human immunodeficiency virus (HIV) infection and antiretroviral therapy (ART) have been a...
Summary: A meta-analysis was conducted to evaluate the prevalence of osteopenia/osteoporosis in huma...